Pipeline
 |
 |
 |
 |
 |
 |
 |
 |
|---|---|---|---|---|---|---|---|
| ONCOLOGY | |||||||
| ARQ 197 | C-Met Inhibitor | Kyowa Hakko4 | |||||
| ARQ 501 | E2F1 Pathway Activator | Roche | |||||
| ARQ 761 | E2F1 Pathway Activator | Roche | |||||
| ARQ 621 | Eg5 Inhibitor | ||||||
| ARQ-350RP | BRAF Kinase Inhibitor | ||||||
| ARQ-250RP | HSP90 Inhibitor | ||||||
| ARQ-700RP | HDAC Inhibitor | ||||||
| NON-ONCOLOGY
ArQule has provided compounds to certain pharmaceutical companies that are pursuing development programs in non-oncology indications. As material information becomes available regarding the status of these programs, ArQule will provide updates through its press releases or filings. |
|||||||